Insider · CIK 0001284500

Traber Peter G

CIK 0001284500 Name as filed on the most recent filing

Filed as Traber Peter G (22)

28 transaction lines · from 22 filings · filed 2012-10-09 to 2023-09-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

28 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-09-25 S, Open-market sale Selecta Biosciences IncSELB 747, disposed Open Form 4 filing 0001453687-23-000067
2023-01-05 S, Open-market sale Selecta Biosciences IncSELB 2 lines 3,913, disposed Open Form 4 filing 0001453687-23-000032
2023-01-04 S, Open-market sale Selecta Biosciences IncSELB 2 lines 9,273, disposed Open Form 4 filing 0001453687-23-000032
2022-01-05 S, Open-market sale Selecta Biosciences IncSELB 9,955, disposed Open Form 4 filing 0001453687-22-000034
2021-12-10 S, Open-market sale Selecta Biosciences IncSELB 12,196, disposed Open Form 4 filing 0001453687-21-000186
2021-10-13 S, Open-market sale Selecta Biosciences IncSELB 15,962, disposed Open Form 4 filing 0001453687-21-000144
2021-05-26 P, Open-market purchase Selecta Biosciences IncSELB 79,850, acquired Open Form 4 filing 0001453687-21-000078
2021-05-25 P, Open-market purchase Selecta Biosciences IncSELB 17,400, acquired Open Form 4 filing 0001453687-21-000074
2021-05-24 P, Open-market purchase Selecta Biosciences IncSELB 41,498, acquired Open Form 4 filing 0001453687-21-000074
2021-03-18 P, Open-market purchase Selecta Biosciences IncSELB 45,000, acquired Open Form 4 filing 0001453687-21-000035
2021-03-17 P, Open-market purchase Selecta Biosciences IncSELB 45,295, acquired Open Form 4 filing 0001453687-21-000035
2020-12-14 P, Open-market purchase Selecta Biosciences IncSELB 129,424, acquired Open Form 4 filing 0001453687-20-000133
2018-06-13 S, Open-market sale Galectin Therapeutics IncGALT 751,000, disposed Open Form 4 filing 0001179022-18-000054
2018-06-08 S, Open-market sale Galectin Therapeutics IncGALT 409,997, disposed Open Form 4 filing 0001179022-18-000050
2015-08-12 P, Open-market purchase Galectin Therapeutics IncGALT 4,000, acquired Open Form 4 filing 0001179022-15-000089
2015-06-01 P, Open-market purchase Galectin Therapeutics IncGALT 10,120, acquired Open Form 4 filing 0001179022-15-000075
2014-08-14 P, Open-market purchase Galectin Therapeutics IncGALT 2 lines 17,838, acquired Open Form 4 filing 0000914062-14-000225
2014-08-13 P, Open-market purchase Galectin Therapeutics IncGALT 4,416, acquired Open Form 4 filing 0000914062-14-000222
2013-12-09 P, Open-market purchase Galectin Therapeutics IncGALT 4,450, acquired Open Form 4 filing 0000914062-13-000371
2013-12-05 P, Open-market purchase Galectin Therapeutics IncGALT 4,500, acquired Open Form 4 filing 0000914062-13-000369
2013-11-19 P, Open-market purchase Galectin Therapeutics IncGALT 5,530, acquired Open Form 4 filing 0000914062-13-000328
2013-11-18 P, Open-market purchase Galectin Therapeutics IncGALT 5,799, acquired Open Form 4 filing 0000914062-13-000322
2012-10-12 P, Open-market purchase Galectin Therapeutics IncGALT 5,287, acquired Open Form 4 filing 0000914062-12-000274
2012-10-09 P, Open-market purchase Galectin Therapeutics IncGALT 5,000, acquired Open Form 4 filing 0000914062-12-000272
2012-10-08 P, Open-market purchase Galectin Therapeutics IncGALT 10,350, acquired Open Form 4 filing 0000914062-12-000270

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 18
  • Open-market sale 10
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. TRABER PETER G, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001284500

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.